25 related articles for article (PubMed ID: 37951196)
1. Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2.
Liu F; Tang L; Liu H; Chen Y; Xiao T; Gu W; Yang H; Wang H; Chen P
Cell Death Dis; 2024 Apr; 15(4):279. PubMed ID: 38637504
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ferroptosis by POLE2 in gastric cancer cells involves the activation of NRF2/GPX4 pathway.
Jian H; Chen ZQ; Du H; Liao T; Sun YC; Ke D; Yu Y
J Cell Mol Med; 2024 Jan; 28(1):e17983. PubMed ID: 38070189
[TBL] [Abstract][Full Text] [Related]
3. USP14 increases the sensitivity of retinoblastoma to cisplatin by mediating the ferroptosis.
Liu H; Gan Q; Lai Y; Pan Z; Jin Q; Li J; Wang N; Jiao S; Chai Y
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38819674
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-17 alleviates erastin-induced alveolar bone loss by suppressing ferroptosis via interaction between NRF2 and p-STAT3.
Bao J; Wang Z; Yang Y; Yu X; Yuan W; Sun W; Chen L
J Clin Periodontol; 2024 Feb; 51(2):233-250. PubMed ID: 37961757
[TBL] [Abstract][Full Text] [Related]
5. CDKN2A inhibited ferroptosis through activating JAK2/STAT3 pathway to modulate cisplatin resistance in cervical squamous cell carcinoma.
Yong X; Zhang Y; Tang H; Hu H; Song R; Wu Q
Anticancer Drugs; 2024 May; ():. PubMed ID: 38748610
[TBL] [Abstract][Full Text] [Related]
6. Metal-organic framework-mediated siRNA delivery and sonodynamic therapy for precisely triggering ferroptosis and augmenting ICD in osteosarcoma.
Sun N; Lei Q; Wu M; Gao S; Yang Z; Lv X; Wei R; Yan F; Cai L
Mater Today Bio; 2024 Jun; 26():101053. PubMed ID: 38654934
[TBL] [Abstract][Full Text] [Related]
7. Low-energy shock waves promote the cisplatin chemosensitivity of human osteosarcoma MNNG/HOS cells via the P2X7/Akt/mTOR pathway.
Gai N; Ju WN; Yu TC; Qi BC
Ann Med Surg (Lond); 2024 May; 86(5):2665-2670. PubMed ID: 38694312
[TBL] [Abstract][Full Text] [Related]
8. M7824: A promising new strategy to combat cancer immune evasion.
Gatti-Mays ME; Gulley JL
Oncoscience; 2018 Nov; 5(11-12):269-270. PubMed ID: 30652109
[No Abstract] [Full Text] [Related]
9. Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma.
Chen R; Zhu S; Zhao R; Liu W; Jin L; Ren X; He H
Front Pharmacol; 2024; 15():1402514. PubMed ID: 38711989
[TBL] [Abstract][Full Text] [Related]
10. Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer.
Su H; Peng C; Liu Y
Front Cell Dev Biol; 2024; 12():1372330. PubMed ID: 38562143
[TBL] [Abstract][Full Text] [Related]
11. Yi-qi-hua-yu-jie-du decoction induces ferroptosis in cisplatin-resistant gastric cancer via the AKT/GSK3β/NRF2/GPX4 axis.
Huang W; Wen F; Yang P; Li Y; Li Q; Shu P
Phytomedicine; 2024 Jan; 123():155220. PubMed ID: 38056149
[TBL] [Abstract][Full Text] [Related]
12. Curcumin induces ferroptosis and apoptosis in osteosarcoma cells by regulating Nrf2/GPX4 signaling pathway.
Yuan C; Fan R; Zhu K; Wang Y; Xie W; Liang Y
Exp Biol Med (Maywood); 2023 Dec; 248(23):2183-2197. PubMed ID: 38166505
[TBL] [Abstract][Full Text] [Related]
13. Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling.
Zhou Q; Hu T; Xu Y
J Drug Target; 2020 Feb; 28(2):204-211. PubMed ID: 31305159
[TBL] [Abstract][Full Text] [Related]
14. Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody.
He J; Zhang W; Di T; Meng J; Qi Y; Li G; Zhang Y; Su H; Yan W
Biomed Pharmacother; 2020 Nov; 131():110541. PubMed ID: 33152901
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic acid enhances the sensitivity of osteosarcoma to cisplatin by inducing ferroptosis through the DNA-PKcs/AKT/NRF2 pathway and reducing PD-L1 expression to attenuate immune evasion.
Zhang Y; Shen G; Meng T; Lv Z; Li X; Li J; Li K
Int Immunopharmacol; 2023 Dec; 125(Pt B):111181. PubMed ID: 37951196
[TBL] [Abstract][Full Text] [Related]
16. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
Liu Q; Wang K
Cell Biol Int; 2019 Nov; 43(11):1245-1256. PubMed ID: 30811078
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
